Format

Send to

Choose Destination
Nat Nanotechnol. 2009 Jul;4(7):411-4. doi: 10.1038/nnano.2009.175. Epub 2009 Jun 28.

Evaluation of nanoparticle immunotoxicity.

Author information

1
Nanotechnology Characterization Laboratory, SAIC-Frederick Inc., NCI-Frederick, Frederick, Maryland 21702, USA. marina@mail.nih.gov

Abstract

The pharmaceutical industry is developing increasing numbers of drugs and diagnostics based on nanoparticles, and evaluating the immune response to these diverse formulations has become a challenge for scientists and regulatory agencies alike. An international panel of scientists and representatives from various agencies and companies reviewed the imitations of current tests at a workshop held at the National Cancer Institute in Frederick, Maryland. This article outlines practical strategies for identifying and controlling interferences in common evaluation methods and the implications for regulation.

PMID:
19581891
DOI:
10.1038/nnano.2009.175
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center